COREY PERRY chairs the firm’s global Employee Benefits and Executive Compensation practice area. Corey advises clients on all types of executive compensation and employee benefit matters, with a specific focus on executive compensation disclosure rules under the federal securities laws. In addition, Corey regularly counsels clients on executive compensation and employee benefits matters related to mergers and acquisitions, divestitures, IPOs, and spinoffs. She advises boards of directors, compensation committees, and management on compensation arrangements, administrative and regulatory compliance with tax and securities laws, and corporate governance considerations regarding executive compensation and related matters.
Partner
Corey Perry
- Capital Markets
- Corporate Governance
- Employee Benefits and Executive Compensation
Experience
- Representative Matters
- Represented American Healthcare REIT, Inc. (AHR), a publicly registered healthcare REIT, in AHR’s US$772.8 million initial public offering and the listing of its common stock on the New York Stock Exchange.
- Represented the underwriters in the upsized US$198.7 million initial public offering by Tyra Biosciences, Inc., a precision oncology company focused on developing purpose-built therapies to overcome tumor resistance and improve outcomes for patients with cancer.
- Represented Box, Inc. in its proxy contest victory over Starboard.
- Represented the underwriters in the US$129.4 million initial public offering by Immuneering Corporation, a biopharmaceutical company with an emerging pipeline focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying translational bioinformatics to every stage of the drug development process. Morgan Stanley, Jefferies, Cowen, and Guggenheim Securities acted as joint book-running managers of the offering.
- Advised Membership Collective Group Inc., a London-based membership and hospitality company (and parent company of Soho House and related businesses), in connection with its initial public offering of US$420 million. MCG sold thirty million shares of its common stock at US$14.00 per share.
Capabilities
SERVICES AND INDUSTRIES
- Capital Markets
- Corporate Governance
- Employee Benefits and Executive Compensation
- Financial Institutions
- REITs
- Compensation and Benefits in M&A Transactions
- Executive Compensation Disclosure
- Pre-Commercial Life Sciences Companies
- Public Companies
- SEC Disclosure
- Section 16 Reporting and Liability
- Taxation of Executive Compensation
News & Insights
Credentials
Admissions & Certifications
- Illinois
Education
- The University of Chicago Law School, J.D., 2004 (with honors)
- University of Illinois, B.S., 1998